Kathrin Bausch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathrin Bausch has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Gernot Bonkat
Alta uro AG, Merian Iselin Klinik, Center of Biomechanics & Calorimetry, University of Basel, 4001 Basel, Switzerland
5 shared publications Hans Helge Seifert
Urologie, Universitätsspital Basel, Basel, Schweiz
5 shared publicationsHans-Helge Seifert
Department of Urology, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland
5 shared publicationsChristian Wetterauer
Department of Urology, University Hospital Basel, Basel, Switzerland
4 shared publications- Jan Adam Roth
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
4 shared publications Jan Ebbing
Department of Urology, University Hospital Basel, Basel, Switzerland
4 shared publications
Latest Publications
- Open Access
Real-World Short-Term Safety of Ultrasound-Guided Suprapubic Trocar Catheter Placement in Neurogenic Lower Urinary Tract Dysfunction: A Retrospective Cohort Study
Objective: To determine the incidence of severe 30-day complications (Clavien–Dindo ≥ III) after ultrasound-guided percutaneous suprapubic catheter placement in patients with neurogenic lower urinary tract dysfunction and to describe overall 30-day safety outcomes. Methods: This retrospective single-centre cohort study included adults with neurogenic lower urinary tract dysfunction who underwent first-time, non-urgent ultrasound-guided percutaneous suprapubic catheter placement between January 2019 and April 2025 and had documented follow-up for at least 30 days. Complications were graded according to the Clavien–Dindo classification; severe complications were defined as grade ≥ III. Potential risk factors were assessed using univariable logistic regression. Results: Of 300 screened patients, 287 were included. Within 30 days, 49/287 patients (17.1%; 95% CI 12.9–21.9) developed at least one complication, and 18/287 (6.3%; 95% CI 3.8–9.7) had a Clavien–Dindo grade ≥ III complication. Grade ≥ IIIb events occurred in 6/287 patients (2.1%; grade IIIb, n = 5; grade IV, n = 1). No confirmed bowel injury was observed. In an exploratory univariable analysis, diabetes mellitus showed a borderline unadjusted association with severe complications (OR 2.86; 95% CI 1.01–7.64; p = 0.049). No multivariable adjustment or multiplicity correction was performed. Conclusions: This study provides confirmatory real-world short-term safety data for selected patients with neurogenic lower urinary tract dysfunction who underwent ultrasound-guided trocar suprapubic catheter placement. No confirmed bowel injury was observed. The diabetes mellitus signal is hypothesis-generating and requires confirmation in larger studies.
Open AccessReal-World Short-Term Safety of Ultrasound-Guided Suprapubic Trocar Catheter Placement in Neurogenic Lower Urinary Tract Dysfunction: A Retrospective Cohort Study
Objective: To determine the incidence of severe 30-day complications (Clavien–Dindo ≥ III) after ultrasound-guided percutaneous suprapubic catheter placement in patients with neurogenic lower urinary tract dysfunction and to describe overall 30-day safety outcomes. Methods: This retrospective single-centre cohort study included adults with neurogenic lower urinary tract dysfunction who underwent first-time, non-urgent ultrasound-guided percutaneous suprapubic catheter placement between January 2019 and April 2025 and had documented follow-up for at least 30 days. Complications were graded according to the Clavien–Dindo classification; severe complications were defined as grade ≥ III. Potential risk factors were assessed using univariable logistic regression. Results: Of 300 screened patients, 287 were included. Within 30 days, 49/287 patients (17.1%; 95% CI 12.9–21.9) developed at least one complication, and 18/287 (6.3%; 95% CI 3.8–9.7) had a Clavien–Dindo grade ≥ III complication. Grade ≥ IIIb events occurred in 6/287 patients (2.1%; grade IIIb, n = 5; grade IV, n = 1). No confirmed bowel injury was observed. In an exploratory univariable analysis, diabetes mellitus showed a borderline unadjusted association with severe complications (OR 2.86; 95% CI 1.01–7.64; p = 0.049). No multivariable adjustment or multiplicity correction was performed. Conclusions: This study provides confirmatory real-world short-term safety data for selected patients with neurogenic lower urinary tract dysfunction who underwent ultrasound-guided trocar suprapubic catheter placement. No confirmed bowel injury was observed. The diabetes mellitus signal is hypothesis-generating and requires confirmation in larger studies.
- Open Access
- 7 September 2026
- Published by Elsevier in European Urology Open Science
- Vol. 92, 50-54
Fungal Urinary Tract Infection: A Brief Manual for Diagnosis and Treatment for Urologists
- 7 September 2026
- Published by Elsevier in European Urology Open Science
- Vol. 92, 50-54
Open AccessFungal Urinary Tract Infection: A Brief Manual for Diagnosis and Treatment for Urologists
- Open Access
- 4 September 2026
- Published by Elsevier in CMI Communications
- Vol. 3 (4)
Methenamine hippurate for prevention of urinary tract infections after endourological procedures: a systematic review
- 4 September 2026
- Published by Elsevier in CMI Communications
- Vol. 3 (4)
Open AccessMethenamine hippurate for prevention of urinary tract infections after endourological procedures: a systematic review
- Open Access
- 12 September 2025
- Published by Elsevier in European Urology Focus
- Vol. 12 (2) , 174-181
Single-dose Versus 3-day Antimicrobial Prophylaxis in Transurethral Resection or Photoselective Vaporization of the Prostate: A Multicenter, Randomized, Placebo Controlled Trial (CITrUS Trial)
- 12 September 2025
- Published by Elsevier in European Urology Focus
- Vol. 12 (2) , 174-181
Open AccessSingle-dose Versus 3-day Antimicrobial Prophylaxis in Transurethral Resection or Photoselective Vaporization of the Prostate: A Multicenter, Randomized, Placebo Controlled Trial (CITrUS Trial)
- 24 July 2025
- Published by Springer Nature
- p. 921-928
Epididymitis
- 24 July 2025
- Published by Springer Nature
- p. 867-877
Uncomplicated Cystitis
- Open Access
A Multicentre Randomised Controlled Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy in Reducing Urinary Tract Infection (APPEAL): Statistical Analysis Plan and Methodology
Background: Urinary tract infection (UTI) is a recognized complication of shock wave lithotripsy (SWL) for urolithiasis. Evidence guiding antibiotic prophylaxis remains of low certainty, contributing to substantial practice variation and conflicting guidelines. A well-powered, blinded randomized trial is essential to provide trustworthy evidence for clinical practice. Study Design: An international, multicentre, randomized controlled trial (the APPEAL trial) assessing the benefits and harms of a single dose of ciprofloxacin versus placebo before SWL in reducing post-procedure UTI. Patients, healthcare providers, data collectors, outcome adjudicators and statisticians blinded to treatment assignment. Endpoints: Appeal’s primary outcome is bacteriuria or symptomatic UTI (symptomatic UTI defined as symptomatic cystitis, pyelonephritis, or urosepsis) within approximately 7-14 days post-SWL. Other outcomes include pyelonephritis or urosepsis, and serious adverse events. Patients and Methods: Over 1,500 patients from high- and middle-income countries undergoing SWL for nephrolithiasis or ureterolithiasis. Exclusion criteria include a positive pre-SWL urine analysis for nitrites or urine culture, ongoing or planned antibiotic use, suspected struvite stones, urinary catheters or diversion, or a history of urosepsis. Imminent report of APPEAL will provide high-quality evidence on the role of antibiotic prophylaxis in SWL and identify subgroups that may benefit most. Trial Registration: ClinicalTrial.gov identifier (ID): NCT03692715 .
Open AccessA Multicentre Randomised Controlled Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy in Reducing Urinary Tract Infection (APPEAL): Statistical Analysis Plan and Methodology
Background: Urinary tract infection (UTI) is a recognized complication of shock wave lithotripsy (SWL) for urolithiasis. Evidence guiding antibiotic prophylaxis remains of low certainty, contributing to substantial practice variation and conflicting guidelines. A well-powered, blinded randomized trial is essential to provide trustworthy evidence for clinical practice. Study Design: An international, multicentre, randomized controlled trial (the APPEAL trial) assessing the benefits and harms of a single dose of ciprofloxacin versus placebo before SWL in reducing post-procedure UTI. Patients, healthcare providers, data collectors, outcome adjudicators and statisticians blinded to treatment assignment. Endpoints: Appeal’s primary outcome is bacteriuria or symptomatic UTI (symptomatic UTI defined as symptomatic cystitis, pyelonephritis, or urosepsis) within approximately 7-14 days post-SWL. Other outcomes include pyelonephritis or urosepsis, and serious adverse events. Patients and Methods: Over 1,500 patients from high- and middle-income countries undergoing SWL for nephrolithiasis or ureterolithiasis. Exclusion criteria include a positive pre-SWL urine analysis for nitrites or urine culture, ongoing or planned antibiotic use, suspected struvite stones, urinary catheters or diversion, or a history of urosepsis. Imminent report of APPEAL will provide high-quality evidence on the role of antibiotic prophylaxis in SWL and identify subgroups that may benefit most. Trial Registration: ClinicalTrial.gov identifier (ID): NCT03692715 .
- Open Access
- 1 November 2024
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 154 (11) , 3933
Exploring the real-world management of catheter-associated urinary tract infections by Swiss general practitioners and urologists: insights from an online survey
AIM: To assess and compare the real-world management of catheters and catheter-associated urinary tract infections (CAUTI) among Swiss general practitioners and urologists, encompassing diagnosis, treatment and prophylaxis. METHODS: An anonymised online questionnaire was distributed among Swiss general practitioners and urologists between January and October 2023 via the networks of Sentinella and the Swiss Association of Urology. The questionnaire consisted of questions on catheter management, including diagnosis, treatment and prophylaxis of CAUTI. Analysis was performed by discipline. Fisher’s exact test was applied for comparisons (statistical significance with p <0.05). RESULTS: Out of 175 participating physicians, the majority were involved in catheter management. Urologists exhibited significantly higher levels of competence as compared to general practitioners (67.1% vs 20.9%). Although no significant differences were observed regarding diagnostic approaches between disciplines, unrecommended diagnostic methods were frequently applied. general practitioners reported that they treated non-febrile CAUTI for longer durations, while urologists indicated that they treated febrile CAUTI longer. Additionally, the use of fluoroquinolones was more prevalent among general practitioners compared to urologists, while prophylactic measures were more frequently applied by urologists. CONCLUSIONS: Catheter and CAUTI management entail significant uncertainty for general practitioners. CAUTI management varied notably between general practitioners and urologists in terms of treatment and prophylaxis. The use of non-recommended diagnostic approaches and drugs was common. This trend, along with inappropriate diagnostic methods and prophylaxis, may increase antimicrobial resistance and CAUTI morbidity. The study emphasises the necessity for diagnostic and antimicrobial stewardship interventions, and proper training in CAUTI management for general practitioners and urologists.
- 1 November 2024
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 154 (11) , 3933
Open AccessExploring the real-world management of catheter-associated urinary tract infections by Swiss general practitioners and urologists: insights from an online survey
AIM: To assess and compare the real-world management of catheters and catheter-associated urinary tract infections (CAUTI) among Swiss general practitioners and urologists, encompassing diagnosis, treatment and prophylaxis. METHODS: An anonymised online questionnaire was distributed among Swiss general practitioners and urologists between January and October 2023 via the networks of Sentinella and the Swiss Association of Urology. The questionnaire consisted of questions on catheter management, including diagnosis, treatment and prophylaxis of CAUTI. Analysis was performed by discipline. Fisher’s exact test was applied for comparisons (statistical significance with p <0.05). RESULTS: Out of 175 participating physicians, the majority were involved in catheter management. Urologists exhibited significantly higher levels of competence as compared to general practitioners (67.1% vs 20.9%). Although no significant differences were observed regarding diagnostic approaches between disciplines, unrecommended diagnostic methods were frequently applied. general practitioners reported that they treated non-febrile CAUTI for longer durations, while urologists indicated that they treated febrile CAUTI longer. Additionally, the use of fluoroquinolones was more prevalent among general practitioners compared to urologists, while prophylactic measures were more frequently applied by urologists. CONCLUSIONS: Catheter and CAUTI management entail significant uncertainty for general practitioners. CAUTI management varied notably between general practitioners and urologists in terms of treatment and prophylaxis. The use of non-recommended diagnostic approaches and drugs was common. This trend, along with inappropriate diagnostic methods and prophylaxis, may increase antimicrobial resistance and CAUTI morbidity. The study emphasises the necessity for diagnostic and antimicrobial stewardship interventions, and proper training in CAUTI management for general practitioners and urologists.
- Open Access
- 17 September 2024
- Published by Elsevier in European Urology Open Science
- Vol. 69, 63-70
Catheter-associated Urinary Tract Infections—Online Questionnaire: Status Quo in Central European Urological Management of Catheter-associated Urinary Tract Infection
- 17 September 2024
- Published by Elsevier in European Urology Open Science
- Vol. 69, 63-70
Open AccessCatheter-associated Urinary Tract Infections—Online Questionnaire: Status Quo in Central European Urological Management of Catheter-associated Urinary Tract Infection
- Open Access
- 31 August 2024
- Published by Elsevier in European Urology Focus
- Vol. 10 (5) , 731-733
Urinary Infection Management in Frail or Comorbid Older Individuals
- 31 August 2024
- Published by Elsevier in European Urology Focus
- Vol. 10 (5) , 731-733
Open AccessUrinary Infection Management in Frail or Comorbid Older Individuals